Answers are grounded in this paper and cite their sources.
Demonstrates effective treatment for monostotic fibrous dysplasia, highlighting low recurrence rates.
Background Monostotic fibrous dysplasia (MFD) involving the upper extremity is typically amenable to conservative treatment. However, surgery may be indicated in the presence of fragility fractures. While curettage with bone grafting is often used, graft resorption and local recurrence are common. Purposes This study aimed to introduce a novel and effective treatment modality for monostotic fibrous dysplasia. Methods This article describes 3 consecutive patients with MFD who underwent curettage with autograft cancellous bone chips, using a trapdoor technique with adjuvant dehydrated alcohol and cryoablation. Results The patients had a mean age of 11.5 years at initial presentation, with average age of operation at 13.7 years. The mean follow-up of all patients included was 3.4 years. All 3 patients showed excellent improvement in function and good bone remodelling. There was no recurrence or refracture. Conclusions Recurrence can be minimised using adjuvants such as cryoablation and dehydrated alcohol, over curettage alone. Our technique of cryoablation using dry nitrogen chip packing over traditional liquid nitrogen is also safer for the patient and surgeon. This is the first description of the use of the trapdoor technique or adjuvant dehydrated alcohol for fibrous dysplasia in the literature. This novel combination technique can be adopted effectively in both skeletally mature and immature patients showing great remodelling potential without growth arrest.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: